Patents
Patents for C07C 255 - Carboxylic acid nitriles (27,066)
07/2006
07/25/2006CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof
07/20/2006WO2006075328A1 Compounds having improved 2-photon absorbance for nonlinear applications
07/20/2006WO2006075177A1 Process for the manufacture of substituted propionic acids
07/20/2006WO2005051895A8 Organic compounds
07/20/2006WO2005042472A3 Hydroxypropyl amides for the treatment of alzheimer’s disease
07/20/2006US20060161020 2-(Benzoylamino-3-phenylpropylamino]acetamide derivatives prevent the formation of insoluble A beta
07/20/2006US20060161009 Phase change ink formulations, colorant formulations, and methods of forming colorants
07/20/2006US20060160875 Matrix metalloproteinase inhibitors
07/20/2006US20060160847 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives
07/20/2006DE4327748B4 Cyclopropyl- und Cyclobutyl-Derivate Cyclopropyl and cyclobutyl derivatives
07/20/2006CA2594909A1 Process for the manufacture of substituted propionic acids
07/19/2006EP1681058A2 Pharmacologically active cns compounds
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006CN1803285A Selective ammoxidation catalyst for multiple methyl arene, its preparation method and uses
07/19/2006CN1264812C Method for recovering acetonitrile from waste liquor obtained in production of cefoperazone sodium
07/19/2006CN1264811C Process for preparing cyanophenyl derivatives
07/18/2006US7078565 Benzamide derivatives as antagonists of orexin receptors
07/18/2006US7078555 Process for making 5-cyanovaleric acid, adipic acid or dimethyl adipate
07/18/2006US7078552 Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs
07/18/2006US7078139 Electrophotographic photoreceptor for wet development
07/18/2006US7077872 Dyeing keratin fibers using developer ,coupler, oxidizer
07/18/2006CA2190727C Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
07/13/2006WO2006072699A1 Method for the recrystallisation and/or purification of azo-type compounds
07/13/2006WO2005123664A3 Processes for the preparation of 2-cyano-3-naphthalene-1-yl-acrylic acid alkyl or benzyl esters
07/13/2006US20060155140 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors
07/13/2006US20060155139 mixed metal oxide containing at least Mo, Bi, Fe, and one of Na, K Rb and Cs on a silica support; majority of pores have diameters of 20-1000 A based on the total pore volume; reacting propylene, isobutene or tert-butyl alcohol with O2 and NH3 in a fluidized-bed reactor to form (meth)acrylonitrile
07/13/2006US20060155135 Ink jet printing, reacting benzylamine-aldehyde compound with stearyl cyanoacetamide
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154977 Therapeutic molecules and methods-1
07/13/2006DE10209139B4 Tricyclische Verbindungen Tricyclic Compounds
07/12/2006EP1679305A1 9-Substituted minocycline compounds
07/12/2006EP1678122A1 Improved process for the manufacture of citalopram hydrobromide
07/12/2006CN1802355A Aminoalcohol derivatives
07/12/2006CN1802347A Process for recovery of pure acrylonitrile
07/12/2006CN1800184A Synthesis of temozolomide and analogs
07/12/2006CN1800155A Novel liquid crystal compound 4'-(2-phenoxyethoxy-1)-4- diphenylcarboxylic acid-2-fluo-4-hydroxybenzenenitrile ester and its preparation method
07/12/2006CN1800154A Novel liquid crystal compound 4'-(3-methylbutoxy-1)-4- diphenylcarboxylic acid-2-fluo-4-hydroxybenzenenitrile ester and its preparation method
07/12/2006CN1800153A Novel liquid crystal compound-3-[4- ú¿propenyl-2-oxy-1ú®-benzyl]acrylic acid-2-fluo-4-hydroxybenzenenitrile ester and its preparation method
07/12/2006CN1800152A Novel liquid crystal compound-3-ú¿4-n-dekaoxylbenzylú®acrylic acid-2-fluo-4-hydroxybenzenenitrile ester and its preparation method
07/12/2006CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels
07/11/2006US7074956 Hydrothermally synthesized catalysts comprising a mixed metal oxide are utilized to produce unsaturated carboxylic acids by the vapor phase oxidation of an alkane, or an alkene
07/11/2006US7074936 Analyzing hydrophobic proteins; laser desorption ionization spectroscopy
07/11/2006US7074921 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds
07/11/2006US7074836 Para-terphenyl compounds
07/11/2006US7074534 Polymeric charge transport compositions and electronic devices made with such compositions
07/11/2006US7074243 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds
07/11/2006CA2364718C Monoamine reuptake inhibitors for treatment of cns disorders
07/11/2006CA2298563C Method for preparing substituted benzyl bromides
07/06/2006WO2006071663A1 Process for the synthesis of glycolonitrile
07/06/2006WO2006070878A1 Carboxylic acid derivative or salt thereof
07/06/2006WO2006041797A3 Acyclic hydrazides as cannabinoid receptor modulators
07/06/2006WO2005108347A3 Substituted enaminones, their derivatives and uses thereof
07/06/2006WO2005044783A8 Acetonitrile recycling process
07/06/2006US20060149093 Process for saparating a hydroxybenzonitrile-type compound
07/06/2006US20060149092 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
07/06/2006US20060148893 Chemical compounds
07/06/2006US20060148892 Process for preparing gamma-cyhalothrin
07/06/2006DE112004000265T5 Neuartige photolabile Schutzgruppen für verbesserte Verfahren zur Herstellung von Oligonukleotid-Arrays Novel photolabile protecting groups for improved methods for the preparation of oligonucleotide arrays
07/06/2006DE102004063381A1 Producing 3-pentenonitrile comprises isomerizing 2-methyl-3-butenonitrile and separating (Z)-2-methyl-2-butenonitrile and 2-methyl-3-butenonitrile
07/05/2006EP1675831A2 Synthetic method for the preparation of quinazolin-4-one derivatives
07/05/2006EP1675821A1 Phenetanolamine derivatives
07/05/2006EP1675594A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/05/2006EP0918514B9 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
07/05/2006CN1798729A Benzamide nitrile derivatives
07/04/2006US7071348 Absorption; withdrawal; extractive distillation
07/04/2006US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives
07/04/2006US7070892 Imaging members
06/2006
06/29/2006WO2006067430A1 2-amino-1-phenylethylcarboxamide derivatives
06/29/2006WO2006067315A1 Method for preparing azo derivatives disubstituted by oxidising corresponding hydrazo derivatives
06/29/2006WO2006066630A1 Material for doped and undoped hole and electron transport layer
06/29/2006WO2006066437A1 5-(2,2-dimethyl-cycloprodyl)-3-methyl-pen-2-enenitrile as fragrance and flavour
06/29/2006US20060142627 Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same
06/29/2006US20060142610 Process for the racemisation of enantiomerically enriched alpha-amino nitriles
06/29/2006US20060142609 Method of producing nitrile compounds from ethylenically-unsaturated compounds
06/29/2006US20060142596 Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates
06/29/2006US20060142586 Synthesis of 2-alkyl amino acids
06/29/2006US20060142567 Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates
06/29/2006US20060142387 Naphthylamine compounds such as N-(cyclopropylmethyl)-N-(4-nitro-1-naphthyl)-N-propylamine; selective androgen receptor modulators; osteoporosis, muscle wasting, frailty, cardiovascular disease, hormone-dependent cancers, dyslipidemia, menopausal vasomotor conditions, sexual disorders
06/29/2006US20060142384 2-Oxyamino-1-cyclopentene-1-nitriles as material protective agents
06/29/2006DE112005000007T5 Katalysator zur Partialoxidation und Verfahren zur Herstellung desselben A catalyst for partial oxidation thereof and methods for preparing
06/28/2006EP1673336A1 Cathepsin cysteine protease inhibitors
06/28/2006EP1673078A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
06/28/2006EP1254159B9 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides
06/28/2006CN1795170A Method for producing purified 2-cyanoacrylate
06/28/2006CN1261408C Preparation of nitrile compounds
06/27/2006US7067697 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy
06/27/2006US7067694 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
06/27/2006US7067685 Phosphonites, use thereof as ligand in transition metal complexes and method for production of nitriles
06/27/2006US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses
06/27/2006US7067546 high yield, industrial scale crystallization of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (Candesartan) from solution or suspension with an aprotic polar solvent, between zero and 30 degrees Celsius
06/27/2006US7067542 Diaminediols for the treatment of Alzheimer's disease
06/27/2006US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol
06/27/2006US7067179 compounds such as 2-propyl-7-(3,5-difluorophenyl)-9,10-dihydrophenanthrene, used in liquid crystal displays having stability at low temperatures; optical and electro-optical apparatus
06/22/2006WO2006064296A1 Process for the preparation of (e)-n,n-diethyl-2-cyano-3(3,4-dihydroxy-5-nitro-phenyl)-acrylamide in stable polymorphic form and intermediates of the process
06/22/2006US20060135808 Novel intermediates for use in retinoid synthesis
06/22/2006US20060135805 Process for the preparation of phenylmalonic acid dinitriles
06/22/2006US20060135790 Process for the preparation of an alpha-amino carbonyl compound
06/22/2006US20060135502 Cyclic derivatives as modulators of chemokine receptor activity
06/22/2006US20060135478 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
06/22/2006US20060134425 Organic luminescence device (OLED) containing both a 5,5'-spirobi(dibenzosilole) compound and a diarylaminofluorene compound; spiro compounds have improved electron-transporting property, luminescence, and durability
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 271